Zacks Research Forecasts Weaker Earnings for Elevance Health

Elevance Health, Inc. (NYSE:ELV) – Zacks Research cut their Q1 2025 earnings estimates for shares of Elevance Health in a research report issued on Thursday, January 30th. Zacks Research analyst K. Dey now expects that the company will post earnings per share of $10.40 for the quarter, down from their previous forecast of $10.76. The consensus estimate for Elevance Health’s current full-year earnings is $34.09 per share. Zacks Research also issued estimates for Elevance Health’s Q3 2025 earnings at $8.59 EPS and FY2027 earnings at $49.16 EPS.

A number of other equities analysts have also recently issued reports on the stock. StockNews.com cut shares of Elevance Health from a “buy” rating to a “hold” rating in a research note on Monday, January 27th. Barclays raised their price target on shares of Elevance Health from $501.00 to $512.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. TD Cowen lowered their price objective on Elevance Health from $589.00 to $484.00 and set a “buy” rating on the stock in a research report on Monday, October 21st. Morgan Stanley decreased their price target on Elevance Health from $643.00 to $551.00 and set an “overweight” rating for the company in a research note on Wednesday, October 23rd. Finally, Truist Financial dropped their price objective on Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Elevance Health currently has a consensus rating of “Moderate Buy” and an average target price of $517.03.

Elevance Health Stock Down 0.9 %

Shares of NYSE:ELV opened at $395.82 on Friday. Elevance Health has a 12-month low of $362.21 and a 12-month high of $567.26. The stock has a market capitalization of $91.80 billion, a price-to-earnings ratio of 15.46, a PEG ratio of 1.20 and a beta of 0.84. The stock has a fifty day simple moving average of $386.63 and a two-hundred day simple moving average of $458.75. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71.

Elevance Health (NYSE:ELV) last released its earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%.

Elevance Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be issued a $1.71 dividend. This is a boost from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date is Monday, March 10th. Elevance Health’s dividend payout ratio (DPR) is currently 25.46%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Quarry LP purchased a new stake in Elevance Health in the 2nd quarter worth $73,000. EP Wealth Advisors LLC lifted its holdings in shares of Elevance Health by 18.1% in the second quarter. EP Wealth Advisors LLC now owns 1,882 shares of the company’s stock worth $1,020,000 after buying an additional 289 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of Elevance Health during the second quarter worth $12,805,000. Healthcare of Ontario Pension Plan Trust Fund grew its stake in Elevance Health by 41.6% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 50,000 shares of the company’s stock valued at $27,093,000 after acquiring an additional 14,700 shares in the last quarter. Finally, Anchor Investment Management LLC lifted its stake in Elevance Health by 4.3% in the 2nd quarter. Anchor Investment Management LLC now owns 4,963 shares of the company’s stock worth $2,689,000 after purchasing an additional 204 shares in the last quarter. 89.24% of the stock is owned by hedge funds and other institutional investors.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.